Yiming Leng

Dr. Yiming Leng


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2019 in BMJ
Verified
Journal Article
Open access
PDF file
SYShang-He-Lin Yin
Shang-He-Lin Yin
PXPeng Xu
Peng Xu
BWBian Wang
Bian Wang
YLYao Lu
Yao Lu
QWQiao-Yu Wu
Qiao-Yu Wu
YLYiming Leng
Yiming Leng
Objective To evaluate the efficacy and safety of standard term (12 months) or long term (>12 months) dual antiplatelet therapy (DAPT) versus short term (<6 months) DAPT after percutaneous coronary intervention (PCI) with drug-eluting stent (DES). Design Systematic review and network meta-analysis. Data sources Relevant studies published between June 1983 and April 2018 from Medline, Embase, Cochrane Library for clinical trials, PubMed, Web of Science, ClinicalTrials.gov, and Clinicaltrialsregister.eu. Review methods Randomised controlled trials comparing two of the three durations of DAPT (short term, standard term, and long term) after PCI with DES were included. The primary study outcomes were cardiac or non-cardiac death, all cause mortality, myocardial infarction, stent thrombosis, and all bleeding events. Results 17 studies (n=46 864) were included. Compared with short term DAPT, network meta-analysis showed that long term DAPT resulted in higher rates of major bleeding (odds ratio 1.78, 95% confidence interval 1.27 to 2.49) and non-cardiac death (1.63, 1.03 to 2.59); standard term DAPT was associated with higher rates of any bleeding (1.39, 1.01 to 1.92). No noticeable difference was observed in other primary endpoints. The sensitivity analysis revealed that the risks of non-cardiac death and bleeding were further increased for ≥18 months of DAPT compared with short term or standard term DAPT. In the subgroup analysis, long term DAPT led to higher all cause mortality than short term DAPT in patients implanted with newer-generation DES (1.99, 1.04 to 3.81); short term DAPT presented similar efficacy and safety to standard term DAPT with acute coronary syndrome (ACS) presentation and newer-generation DES placement. The heterogeneity of pooled trials was low, providing more confidence in the interpretation of results. Conclusions In patients with all clinical presentations, compared with short term DAPT (clopidogrel), long term DAPT led to higher rates of major bleeding and non-cardiac death, and standard term DAPT was associated with an increased risk of any bleeding. For patients with ACS, short term DAPT presented similar efficacy and safety with standard term DAPT. For patients implanted with newer-generation DES, long term DAPT resulted in more all cause mortality than short term DAPT. Although the optimal duration of DAPT should take personal ischaemic and bleeding risks into account, this study suggested short term DAPT could be considered for most patients after PCI with DES, combining evidence from both direct and indirect comparisons. Systematic review registration PROSPERO CRD42018099519.

1 November 2019 in Applied Catalysis B: Environment and Energy
Verified
Journal Article
Closed access
JYJie Yu
Jie Yu
XHXiaoli Hou
Xiaoli Hou
XHXiantao Hu
Xiantao Hu
HYHong Yuan
Hong Yuan
JWJingyu Wang
Jingyu Wang
CCChuan-Feng Chen
Chuan-Feng Chen

9 September 2020 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
XLX. Liu
X. Liu
QWQ. Wu
Q. Wu
GYG. Yan
G. Yan
JDJ. Duan
J. Duan
ZCZ. Chen
Z. Chen
YLYiming Leng
Yiming Leng

1 May 2019 in Applied Catalysis B: Environment and Energy
Verified
Journal Article
Closed access
XLXia Li
Xia Li
HXHui Xu
Hui Xu
JSJi-Long Shi
Ji-Long Shi
HHHuimin Hao
Huimin Hao
HYHong Yuan
Hong Yuan
XLXianjun Lang
Xianjun Lang

15 January 2020 in Endocrine
Verified
Journal Article
Closed access
PDF file
XLXin-Yao Liu
Xin-Yao Liu
QWQiao-Yu Wu
Qiao-Yu Wu
ZCZhi-Heng Chen
Zhi-Heng Chen
GYGuang-Yu Yan
Guang-Yu Yan
YLYao Lu
Yao Lu
YLYiming Leng
Yiming Leng

19 April 2022 in ACS Catalysis
Verified
Journal Article
Closed access
RLRuizhe Li
Ruizhe Li
YLYuan Li
Yuan Li
ZLZhenhua Li
Zhenhua Li
WWWeiqin Wei
Weiqin Wei
QHQuanguo Hao
Quanguo Hao
Tierui ZhangTierui Zhang
Tierui Zhang